Nausea affects approximately 24-44% of patients using GLP-1 receptor agonists like semaglutide and tirzepatide, though severity varies considerably
Polymorphisms of these genes or associated regulatory sequences, or copy number variations (CNV) may contribute to a reduction in UGT activity or indeed loss of function and, therefore, reduce paracetamol glucuronidation
Caitlins passion for Semaglutide and Tirzepatide therapies goes far beyond basic weight management
Convenient and effective, our Liposomal Glutathione is your daily dose of rejuvenation
Whittle IR, Smith C, Navoo P, Collie D
Note: Always inform your healthcare provider about every supplement you take, including fiber, so they can monitor your progress and adjust your treatment plan if necessary